Gujarat Kidney IPO

Incorporated in 2019, Gujarat Kidney and Super Speciality Limited (GKASSL) specializes in providing multispeciality healthcare services, including secondary and tertiary care, across multiple locations in Gujarat, India. The company operates seven multispeciality hospitals and four pharmacies with a total bed capacity of 490 beds, an approved capacity of 455 beds, and an operational capacity of 340 beds. The company's hospitals include Gujarat Kidney and Superspeciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Palmland Hospital Private Limited (Bharuch), M/s. Surya Hospital and ICU (Borsad), Gujarat Surgical Hospital (Vadodara), and Ashwini Medical Centre (Anand). The company also operates Ashwini Medical Store (Anand). Services: Gujarat Superspeciality Hospital provides medical care in areas such as internal medicine, general surgery, minimally invasive procedures, orthopaedics and trauma treatment, joint replacement surgery, obstetrics and gynaecology, respiratory failure, non-interventional cardiology, diabetology, and anaesthesiology. As of June 30, 2025, the company had 89 Doctors, 332 nurses and 338 other staff. Competitive Strengths:

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 Proposed acquisition of Parekhs Hospital at Ahmedabad. 77.00 2 Part-payment of purchase consideration for the already acquired “Ashwini Medical Centre”. 12.40 3 Funding of capital expenditure requirements of the Company towards setting up of a new hospital in Vadodara. 30.10 4 Buying robotics equipment for our hospital Gujarat Kidney & Super Speciality hospital in Vadodara location. 6.83 5 Full or part repayment and/or prepayment of certain outstanding secured borrowings availed by the Company 1.20 6 Funding inorganic growth through unidentified acquisitions and General Corporate Purposes. 87.44 7 Acquisition of additional shareholding in the subsidiary namely “Harmony Medicare Private Limited” at Bharuch 10.78

All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application. No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever Please read all Tearms and conditions , and agree to use the App